A.L.P.S. Clavicle Plating System PMCF
Condition(s) studied
Investigational drug(s) / intervention(s)
Clavicle open reduction and internal fixation: Clavicle open reduction and internal fixation using the A.L.P.S. Clavicle Plating System
Study summary
A commercially available product clinical study which aims to confirm the safety, performance, and clinical benefits to the patient of the ALPS Clavicle Plating system for both the implant itself and the instrumentation used during surgery.
Eligibility
Primary outcome measure(s)
- Number of subjects with fracture healing — 12 months
Number of subjects with fracture healing will be assessed through 12 months follow-up. Radiologic fracture healing is defined as: Bridging callus or no visible fracture lines on AP and 15-45° cephalic oblique radiographs.
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Cleveland Clinic Florida | Weston | Florida | |
| University of Michigan - Michigan Medicine | Ann Arbor | Michigan | |
| Slocum Research & Education Foundation | Eugene | Oregon | |
| University of Texas San Antonio | San Antonio | Texas | |
| General Foundation of the University of Valladolid | Valladolid | Spain |
More Zimmer Biomet trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05327959 on ClinicalTrials.gov ↗ ← All trials in the USA